Results 211 to 220 of about 36,696 (303)

GLP‐1 Receptor Agonists for the Prevention of New‐Onset Heart Failure: A Systematic Review and Meta‐Analysis of Placebo‐Controlled Randomized Clinical Trials

Obesity Reviews, Volume 27, Issue 4, April 2026.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) improve outcomes in heart failure (HF) with preserved ejection fraction. Whether GLP‐1 RA prevent new‐onset HF in Type 2 diabetes or obesity requires further investigation. Methods We performed an updated meta‐analysis of randomized placebo‐controlled trials (RCT) of treatment ...
João Sérgio Neves, Carolina B. Lobato, Ana Rita Leite, Catarina Vale, Francisco Vasques‐Nóvoa, Francisca Saraiva, Adelino Leite‐Moreira, Jens J. Holst, João Pedro Ferreira   +8 more
wiley   +1 more source

Population attributable fraction of associated factors to adherence to blood glucose self-monitoring in diabetic type 2 patients treated with insulin or sulfonylureas/meglitinides: The results of DiaCare study in Iran. [PDF]

J Educ Health Promot
Mohammadi A, Shafiee G, Olyaeemanesh A, Daroudi R, Aghakhani A, Nasli-Esfahani E, Razi F, Heshmat R, Takian A.   +8 more
europepmc   +1 more source

Determinants and predictive performance of reduced muscle mass in elderly patients with type 2 diabetes: a retrospective study. [PDF]

Front Endocrinol (Lausanne)
Wang K, Fu W, Pan H, Dong J.
europepmc   +1 more source

Tests on Three Antisera und Subsequent Development of Radioimmunoassay for Different Regions of Human parathyrin [PDF]

, 1979
Marschner, I., Scriba, Peter Christian, Wood, W. G.   +2 more
core  

Rapid Residue Analysis of Sulfonylurea Herbicides in Surface Water: Methodology and Residue Findings in eastern Tiaoxi River of China

, 2016
Ninghui Song, Min Guo, Lili Shi
openalex   +2 more sources

Patients' Attitudes Towards Deprescribing Differ Across Specific Cardiovascular and Diabetes Medication: A Survey Study Assessing Within-Patient Differences. [PDF]

Basic Clin Pharmacol Toxicol
Stuijt PJC, Crutzen S, Heringa M, Hootsen JV, van Munster BC, Wildeboer AT, Taxis K, Denig P.   +7 more
europepmc   +1 more source

A Study of the Action of Hypoglycemia-producing Biguanide and Sulfonylurea Compounds on Oxidative Phosphorylation

, 1962
Alfredo Falcone, Rose L. Mao, Earl Shrago   +2 more
openalex   +1 more source

METABOLIC EFFECTS OF SULFONYLUREAS IN NORMAL MEN and IN VARIOUS TYPES OF DIABETIC PATIENTS [PDF]

, 1957
Stefan S. Fajans, Lawrence H. Louis, Allen R. Hennes, B L Wajchenberg, Robert D. Johnson, R Gittler, Irving P. Ackerman, Jerome W. Conn   +7 more
openalex   +1 more source

Comparative cardiovascular risk of sulfonylureas with low- and high-affinities for cardiac mitochondrial adenosine triphosphate-sensitive potassium channels versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A cohort study. [PDF]

Diabetes Obes Metab
Chen MH, Lin LY, Hung TY, Lin TC, Li CY, Lin TH, Chen YH, Liou JT, Wang MT.   +8 more
europepmc   +1 more source

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study [PDF]

, 2009
Jonathan L. Wright, Janet L. Stanford, JS Kasper, KM Waters, SL Bowker, JM Evans, A Vazquez-Martin, Y Zhuang, M Buzzai, I Ben Sahra, RJ Dowling, MB Schneider, M Zakikhani, M Zakikhani, C Algire, I Agalliu, CJ Bailey, TJ Murtola, ME Peek, S Jiralerspong, K Hede, J Hammarsten, J Ma, DG Hardie, SM Hadad, Centers for Disease Control and Prevention (CDC), DM Werny   +26 more
core   +1 more source